The DOI matches its OpenAlex record; 10 of the 10 references it cites were found in a registry or an index.
C-reactive protein: a critical update
Open accessAbstract
In the mid 1990s, immunoassays for C-reactive protein (CRP), with greater sensitivity than those previously in routine use, revealed that increased CRP values, even within the range previously considered normal, strongly predict future coronary events. These findings triggered widespread interest, especially, remarkably, in the US, where the clinical use of CRP measurement had been largely ignored for about 30 years. CRP production is part of the nonspecific acute-phase response to most forms of inflammation, infection, and tissue damage and was therefore considered not to provide clinically useful information. Indeed, CRP values can never be diagnostic on their own and can only be interpreted at the bedside, in full knowledge of all other clinical and pathological results. However, they can then contribute powerfully to management, just as universal recording of the patient’s temperature, an equally nonspecific parameter, is of great clinical utility. The present torrent of studies of CRP in cardiovascular disease and associated conditions is facilitated by the ready commercial availability of automated CRP assays and of CRP itself as a research reagent. However, unlike the earlier rejection in the US of CRP as an empirical test because of its perceived lack of specificity, the current enthusiasm over CRP in cardiovascular disease is widely characterized by failure to recognize appropriately the nonspecific nature of the acute-phase response, and by lack of critical biological judgment. Quality control of the source, purity, and structural and functional integrity of the CRP, and the relevance of experimental design before ascribing pathophysiological functions, are also often ignored. This article provides information about CRP as a protein and an acute-phase reactant, and a knowledge-based framework for interpretation and analysis of clinical observations of CRP in relation to cardiovascular and other diseases. We also review the properties of CRP, its possible role in pathogenesis of disease, and our own observations that identify it as a possible therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692
Ridker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557
The physiological structure of human C-reactive protein and its complex with phosphocholine
Thompson, D., Pepys, M. B., & Wood, S. P. (1999) · Structure · doi:10.1016/s0969-2126(99)80023-9 · Cited by 818
Self-citationCushman, M., Legault, C., Barrett-Connor, E., Stefanick, M. L., Kessler, C., Judd, H. L., Sakkinen, P. A., & Tracy, R. P. (1999) · Circulation · doi:10.1161/01.cir.100.7.717 · Cited by 660
Effect of alcohol consumption on systemic markers of inflammation
Imhof, A., Froehlich, M., Brenner, H., Boeing, H., Pepys, M. B., & Koenig, W. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04170-2 · Cited by 559
Self-citationTargeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis
Pepys, M. B., Herbert, J., Hutchinson, W. L., Tennent, G. A., Lachmann, H. J., Gallimore, J. R., Lovat, L. B., Bartfai, T., Alanine, A., Hertel, C., et al. (2002) · Nature · doi:10.1038/417254a · Cited by 540
Self-citationRegulation of complement activation by C-reactive protein
Mold, C., Gewurz, H., & Du Clos, T. W. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00007-7 · Cited by 326
Research works printed but not linked: 49
- 10.1016/0009-8981(81)90005-X · DOI · Paper page
- 10.1172/JCI116336 · DOI · Paper page
- Hutchinson, 2000, Clin. Chem., 46, 934, 10.1093/clinchem/46.7.934 · DOI
- 10.1038/sj.gene.6363820 · DOI
- Oliveira, 1980, J. Immunol., 124, 1396, 10.4049/jimmunol.124.3.1396 · DOI
- de Beer, 1982, Immunology., 45, 55
- 10.1111/j.1749-6632.1982.tb22125.x · DOI · Paper page
- Pepys, 1985, Int. Rev. Exp. Pathol., 27, 83
- 10.1038/281155a0 · DOI · Paper page
- Du Clos, 1989, J. Immunol., 143, 2553, 10.4049/jimmunol.143.8.2553 · DOI
- 10.1084/jem.192.9.1353 · DOI · Paper page
- 10.1111/j.1749-6632.1982.tb22140.x · DOI · Paper page
- 10.1038/9544 · DOI · Paper page
- 10.1016/S0167-5699(98)01419-4 · DOI · Paper page
- 10.1084/jem.114.6.961 · DOI
- 10.1073/pnas.192399699 · DOI · Paper page
- 10.1136/hrt.47.3.239 · DOI · Paper page
- 10.1016/0002-9149(90)90079-G · DOI · Paper page
- 10.1056/NEJM199408183310701 · DOI · Paper page
- 10.1056/NEJM199503093321003 · DOI · Paper page
- 10.1016/S0140-6736(96)07591-5 · DOI · Paper page
- Kuller, 1996, Am. J. Epidemiol., 144, 537, 10.1093/oxfordjournals.aje.a008963 · DOI · Paper page
- Tracy, 1996, Circulation., 93, 622
- Koenig, 1999, Circulation., 99, 237, 10.1161/01.CIR.99.2.237 · DOI · Paper page
- Danesh, 1998, J. Am. Coll. Cardiol., 279, 1477
- 10.1053/euhj.1998.1309 · DOI · Paper page
- 10.2337/diacare.23.12.1835 · DOI · Paper page
- Chambers, 2001, Circulation., 104, 145, 10.1161/01.CIR.104.2.145 · DOI · Paper page
- 10.2337/diacare.22.12.1971 · DOI · Paper page
- 10.2337/diabetes.51.5.1596 · DOI · Paper page
- 10.1161/01.CIR.0000041046.32962.86 · DOI · Paper page
- 10.1054/fipr.1999.0037 · DOI
- Ridker, 1999, Circulation., 100, 713, 10.1161/01.CIR.100.7.713 · DOI · Paper page
- 10.1097/00001648-200209000-00012 · DOI · Paper page
- Ridker, 1999, Circulation., 100, 230, 10.1161/01.CIR.100.3.230 · DOI · Paper page
- 10.1084/jem.156.1.230 · DOI
- Bhakdi, 1999, Arterioscler. Thromb. Vasc. Biol., 19, 2348, 10.1161/01.ATV.19.10.2348 · DOI · Paper page
- Torzewski, 1998, Arterioscler. Thromb. Vasc. Biol., 18, 1386, 10.1161/01.ATV.18.9.1386 · DOI · Paper page
- 10.1016/S0021-9150(99)00105-7 · DOI · Paper page
- Zwaka, 2001, Circulation., 103, 1194, 10.1161/01.CIR.103.9.1194 · DOI · Paper page
- 10.1002/1521-4141(200112)31:12<3475::AID-IMMU3475>3.0.CO;2-1 · DOI
- 10.1172/JCI12418 · DOI
- Cermak, 1993, Blood., 82, 513, 10.1182/blood.V82.2.513.513 · DOI · Paper page
- Pietilä, 1996, Eur. Heart J., 17, 1345, 10.1093/oxfordjournals.eurheartj.a015068 · DOI · Paper page
- 10.1016/S0002-8703(96)90164-7 · DOI
- Anzai, 1997, Circulation., 96, 778, 10.1161/01.CIR.96.3.778 · DOI · Paper page
- 10.1172/JCI104715 · DOI
- Lagrand, 1997, Circulation., 95, 97, 10.1161/01.CIR.95.1.97 · DOI · Paper page
- 10.1084/jem.190.12.1733 · DOI · Paper page
Cited by
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Self-citationLee, D. W., Kochenderfer, J. N., Stetler-Stevenson, M., Cui, Y. K., Delbrook, C., Feldman, S. A., Fry, T. J., Orentas, R., Sabatino, M., Shah, N. N., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61403-3 · Cited by 2,898
Current concepts in the diagnosis and management of cytokine release syndrome.
Lee, D. W., Gardner, R., Porter, D. L., Louis, C. U., Ahmed, N., Jensen, M., Grupp, S. A., & Mackall, C. L. (2014) · Blood · doi:10.1182/blood-2014-05-552729 · Cited by 2,806
Metadata
- Authors
- Pepys, M. B., & Hirschfield, G. M.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-06-15
- Volume
- 111
- Issue
- 12
- Pages
- 1805-1812
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2024886564
- Cited by
- 3,503
- References
- 10
- FWCI
- 27.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: C-reactive protein: a critical update. https://app.cochat.ai/papers/10.1172/jci18921
- The paper
- Pepys, M. B., & Hirschfield, G. M. (2003). C-reactive protein: a critical update. Journal of Clinical Investigation. https://doi.org/10.1172/jci18921
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.